NRO Neurones SA

NEURONES: Implementation of a new liquidity contract with Crédit Industriel et Commercial (CIC)

NEURONES: Implementation of a new liquidity contract with Crédit Industriel et Commercial (CIC)

PRESS INFORMATION

Nanterre, 31 July 2019

Heading: liquidity contract

Implementation of a new liquidity contract

with Crédit Industriel et Commercial (CIC)

Effective 1 August 2019, NEURONES has commissioned Crédit Industriel et Commercial (CIC) to implement a liquidity contract concerning its own shares, to replace the current contract with CM-CIC Securities which comes to an end on 31 July.

This agreement has been drawn up in accordance with applicable regulations, in particular AMF Decision No. 2018-01 of 2 July 2018. It is compliant with the ethics charter of the French Financial Markets Association (AMAFI).

Euronext remains the negotiating platform for transactions relating to this new liquidity contract.

Funds of 400,000 euros in cash have been allocated for its implementation.

It is stipulated that the situations or conditions that could lead to its suspension or cessation are the following:

  • The conditions covered by Article 5 of the above-mentioned AMF Decision;
  • At the request of the issuer for the period specified by him;
  • At the initiative of the operator, if information brought to his attention prevents him from continuing to fulfil his obligations.

The contract may furthermore be terminated at any time by NEURONES or by CIC with 30 days’ notice.

About NEURONES

With over 5,200 experts, the NEURONES group specializes in Consulting (Management, Organization and Digital) and Digital Services (Infrastructures and Applications). It supports its clients in their digital transformation projects and in the upgrading of their information systems.

Euronext Paris (compartment B - NRO) - Enternext Tech 40 - SRD medium values



Press Relations:

O’Connection

Floriane MONNIER

Tel: +33 (6) 32 37 57 28

 



NEURONES

Matthieu VAUTIER

Tel: +33 (1) 41 37 41 37



Investor Relations:

NEURONES

Paul-César BONNEL

Tel: +33 (1) 41 37 41 37



Attachment

EN
31/07/2019

Underlying

To request access to management, click here to engage with our
partner Phoenix-IR's CorporateAccessNetwork.com

Reports on Neurones SA

 PRESS RELEASE

NEURONES: 5.1% organic growth in 2025

NEURONES: 5.1% organic growth in 2025 PRESS INFORMATIONHeading: 2025 annual revenues        Nanterre, February 11, 2026 (after trading) 5.1% organic growth in 2025 (being audited, in € millions)20242025Growthof which organic4rd quarter revenues211.3225+ 6.5%+ 6.2%Annual revenues810.4857.2+ 5.8%+ 5.1% Achievements NEURONES closes the financial year with annual revenue of €857.2 million, exceeding its expectations. Growth is driven by digital and data projects (double-digit growth), while AI-related activities confirm a promising upward trend. With its decentralized and responsive structu...

 PRESS RELEASE

NEURONES : + 5,1% de croissance organique en 2025

NEURONES : + 5,1% de croissance organique en 2025 INFORMATION PRESSERubrique : C.A. annuel 2025        Nanterre, le 11 février 2026 (après Bourse) + 5,1% de croissance organique en 2025 (en cours d’audit, en M€)20242025Croissancedont organiqueChiffre d’affaires 4e trimestre211,3225+ 6,5%+ 6,2%Chiffre d’affaires annuel810,4    857,2+ 5,8%+ 5,1% Réalisations NEURONES clôture l’exercice avec un chiffre d’affaires annuel de 857,2 M€, dépassant ainsi ses anticipations. La croissance est portée par les projets digitaux et data (progression à deux chiffres), tandis que les activités liées à l’I...

 PRESS RELEASE

NEURONES: Organic growth up 5.1% in 3rd quarter 2025

NEURONES: Organic growth up 5.1% in 3rd quarter 2025 PRESS INFORMATIONHeading: 3rd quarter 2025 revenues        Nanterre, November 5, 2025 (after trading) Organic growth up 5.1% in 3rd quarter 2025 (not audited, in millions of euros)20242025growthof which organic3rd quarter revenues196.7207.9+ 5.7%+ 5.1%Total as at the end-September599.1632.2+ 5.5%+ 4.7% Achievements In a declining French market, NEURONES has continued its momentum in the third quarter, in line with the start of the year. Growth is particularly strong in the areas of Data & AI, digital projects, ITSM (Ser...

 PRESS RELEASE

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025

NEURONES : + 5,1% de croissance organique au 3e trimestre 2025 INFORMATION PRESSERubrique : C.A. 3e trimestre 2025        Nanterre, le 5 novembre 2025 (après Bourse) + 5,1% de croissance organique au 3e trimestre 2025 (non audités, en millions d’euros)20242025croissancedont organiqueChiffre d’affaires 3e trimestre196,7207,9+ 5,7%+ 5,1%Cumul à fin septembre599,1632,2+ 5,5%+ 4,7% Réalisations Dans un marché français en repli, NEURONES a poursuivi sa dynamique au 3e trimestre, dans la continuité du début de l’année. La croissance est particulièrement soutenue dans les domain...

 PRESS RELEASE

NEURONES: Declaration of transactions on treasury shares (October 13 t...

NEURONES: Declaration of transactions on treasury shares (October 13 to 17, 2025) Nanterre, October 21, 2025 Declaration of transactions on treasury shares(period from 13 to 17 October 2025) As part of the share buyback program authorized by the General Meeting of June 5, 2025, NEURONES made the following purchases between October 13 and 17, 2025 (ISIN code FR0004050250): DayTotal daily volume(in number of shares)Weighted average price(unit daily)10/16/202510,000€38.0510/17/2025      489€38.10Total10,489  As of October 17, 2025, excluding the liquidity contract, NEURONES now holds 10,489 ...

ResearchPool Subscriptions

Get the most out of your insights

Get in touch